US2022330856A1PendingUtilityA1

Analyte monitoring devices and methods

Assignee: ABBOTT DIABETES CARE INCPriority: Oct 7, 2010Filed: Nov 22, 2021Published: Oct 20, 2022
Est. expiryOct 7, 2030(~4.2 yrs left)· nominal 20-yr term from priority
A61B 5/0004G16H 20/17A61B 5/14532A61B 5/6833A61B 5/1486A61B 5/14546G16H 50/20A61B 2560/0462A61B 5/14865G16H 40/63A61B 5/1473A61B 5/01
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods and devices for providing application specific integrated circuit architecture for a two electrode analyte sensor or a three electrode analyte sensor are provided. Systems and kits employing the same are also provided.

Claims

exact text as granted — not AI-modified
1 - 20 . (canceled) 
     
     
         21 . An analyte monitoring device, comprising:
 an analyte sensor including an in vivo portion configured for fluid contact with a bodily fluid under a skin layer, the analyte sensor configured to monitor an analyte level in the bodily fluid and generate one or more signals associated with the monitored analyte level; and   sensor electronics including a sensor interface section and a temperature detection circuit, wherein the temperature detection circuit comprises:
 a reference resistor; 
 a resistance temperature device; and 
 a current source switchably coupled with the reference resistor and the resistance temperature device. 
   
     
     
         22 . The analyte monitoring device of  claim 21 , wherein the temperature detection circuit is configured to measure skin temperature.

Join the waitlist — get patent alerts

Track US2022330856A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.